NATCOPHARM.BONATCOPHARM.BOBSE
Loading
Gross Profit Over TimeExpanding
Percentile Rank100
3Y CAGR+39.6%
5Y CAGR+19.7%
Studio
Year-over-Year Change

Revenue minus cost of goods sold

3Y CAGR
+39.6%/yr
vs -5.9%/yr prior
5Y CAGR
+19.7%/yr
Recent acceleration
Acceleration
+45.5pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
2.5x
Strong expansion
Streak
3 yr
Consecutive growthExpanding
PeriodValueYoY Change
2025$37.05B+13.9%
2024$32.53B+58.4%
2023$20.54B+50.8%
2022$13.62B-10.7%
2021$15.24B+1.0%
2020$15.09B-11.9%
2019$17.13B-1.3%
2018$17.35B+24.6%
2017$13.92B+76.6%
2016$7.88B-